The use of skin testing in the investigation of toxidermia: From pathophysiology to results of skin testing;Tests cutanés dans l'investigation des toxidermies: De la physiopathologie aux résultats des investigations

Therapie

Volumn 57, Issue 3, 2002, Pages 258-262

  Barbaud, A ^a  

^a Hospital Villemin   (France)

Author keywords

Cutaneous adverse drug reactions; Skin testing

Indexed keywords

DRUG; IMMUNOGLOBULIN E;

ANTIGEN ANTIBODY COMPLEX; CLINICAL FEATURE; CONFERENCE PAPER; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; ECZEMA; EOSINOPHILIA; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INTRACUTANEOUS TEST; PAPULAR SKIN DISEASE; PATCH TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUSTULOSIS; SKIN TEST; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS;

DRUG ERUPTIONS; HUMANS; SKIN; SKIN TESTS;

EID: 0036588272     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Barbaud A, Béné MC, Faure GC. Immunological physiopathology of cutaneous adverse drug reactions. Eur J Dermatol 1997; 7: 319-323
2. Martin S. Barbaud A, Schmutz JL, et al. Polyclonalité de la réponse lymphocytaire T dans les tests d'activation lymphocytaire médicamenteux. Ann Dermatol Vénéréol 2000; 127: 268-272
3. Mauri-Helweg D, Zanni M, Frei E, et al. Cross-reactivity of T cell clones to beta-lactam antibiotics. J Immunol 1996; 157: 1071-1079
4. Barbaud A, Tréchot P. Quoi de neuf concernant les toxidermies? In Progrès en dermato-allergologie, John Libbey ed (Montrouge, France), tome 6, 2001; 225-236
5. Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematous pustulosis (AGEP). A clinical reaction pattern. J Cutan Pathol 2001; 28: 113-119
6. Barbaud A. Quoi de neuf en 20 ans dans les toxidermies chez l'immunocompétent? Nouv Dermatol 2001; 20: 456-459
7. Wolkenstein P, Chosidow O, Fléchet M-L, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35: 234-236
8. Sparsa A, Loustaud-Ratti V, Mousset-Hovaere M, et al. Syndrome d'hypersensibilité médicamenteuse en pratique interniste: pièges diagnostique et thérapeutique. Huit observations. Rev Med Interne 2000; 21: 1052-1059
9. Descamps V. Valance A, Eldinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001; 137: 301-304
10. Assier H, Bastuji-Garin S, Revuz J, et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995; 131: 539-543. (réponse Bystryn JC. Arch Dermatol 1996; 132: 711)
11. Klein CE, Trautmann A, Zillikens D, et al. Patch testing in an unusual case of toxic epidermal necrolysis. Contact Dermatitis 1995; 33: 448-449
12. Alanko K, Stubb S, Reitamo S. Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116: 561-567
13. Barbaud A, Reichert-Penetrat S, Trechot P, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139: 49-58
14. Barbaud A. Bene MC, Faure G, et al. Tests cutanés dans l'exploration des toxidermies supposées de mécanisme immuno-allergique. Bull Acad Natle Med 2000; 184: 47-63
15. Barbaud A, Gonçalo M, Bruynzeel D, et al. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321-28
16. Barbaud A, Tréchot P, Reichert-Pénétrat S, et al. The usefulness of patch testing on the previously most severely affected site in a cutaneous adverse drug reaction to tetrazepam. Contact Dermatitis 2001; 44: 259-260
17. Romano A, Quarantino D, Di Fonso M, et al. A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins. J Allergy Clin Immunol 1999; 103: 1186-1190
18. e cours du GERDA. John Libbey Eurotext, Montrouge 1998; Tome 4: 75-86
19. Figarella I, Barbaud A, Lecompte T, et al. Réaction d'hypersensibilité retardée aux héparines et héparinoïdes. Ann Dermatol Vénéréol 2001; 128: 25-30
20. Barbaud A, Tréchot P, Reichert-Penetrat S, et al. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321-328
21. Choquet-Kastylevsky G, et al. Réactions cutanées médicamenteuses: la réalisation de tests cutanés augmente le score d'imputabilité. Ann Dermatol Vénéréol 2001; 128: 507-11